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Background: Obstructive sleep apnea (OSA) is associated with impaired quality of life (HRQL) or health status. Treatment with continuous positive 
airway pressure (CPAP) has variable impacts on HRQL, which may be influenced by the patient’s tolerance of therapy. We aimed to determine the 
impact of nocturnal supplemental oxygen (NSO) and CPAP on HRQL compared with healthy lifestyle and sleep education (HLSE) in OSA patients.
methods: Patients with coronary heart disease (CHD) or at least 3 major CHD risk factors were recruited from cardiology clinics. Subjects with 
apnea-hypopnea index (AHI) of 15-50 events/hour were randomized to one of three treatment groups: CPAP, NSO, or HLSE. HRQL was assessed using 
the Short-Form-36 (SF-36) and depression was assessed with Patient Health Questionnaire 9 (PHQ-9) at baseline and 12 weeks. Change scores 
were adjusted in multivariable model.
results: A total of 318 patients were randomized (94% completion rate). Mean SF-36 scores were similarly impaired at baseline in all 3 groups 
ranging from 41.8±12 to 51.6±12 across domains. Mean PHQ-9 scores were 6.1±5 (HLSE), 5.2±5 (CPAP), and 5.3±5 (NSO). In multivariable model, 
the CPAP group noted improvement in mental health (Table). Physical function was more improved with NSO. PHQ-9 scores were not independently 
impacted by therapy.
conclusion: In patients with established CHD or multiple CHD risk factors, treatment with CPAP resulted in improved mental health and vitality. 
Physical function was improved with NSO.
Response CPAP - HLSE NSO - HLSE CPAP - NSO
Mean difference in change of response 
(95% CI);
p-value
Mean difference in change of response 
(95% CI);
p-value
Mean difference in change of response 
(95% CI);
p-value
MCS 2.92 (0.55, 5.29)P=0.016 -0.48 (-2.86, 1.89)P=0.691 3.40 (1.01, 5.79)P=0.005
PCS 0.77 (-0.89, 2.43)P=0.363 3.25 (1.58, 4.91)P<0.001 -2.48 (-4.15, -0.80)P=0.004
Vitality (Primary) 2.42 (-0.04, 4.89)P=0.054 1.36 (-1.11, 3.83)P=0.278 1.06 (-1.43, 3.55)P=0.403
Role Physical 2.57 (0.24, 4.89)P=0.031 1.66 (-0.68, 3.99)P=0.163 0.91 (-1.44, 3.26)P=0.446
Physical function -0.50 (-2.56, 1.56)P=0.632 2.64 (0.57, 4.70)P=0.012 -3.14 (-5.21, -1.06)P=0.003
Role Emotional 2.37 (-0.45, 5.18)P=0.099 0.37 (-2.45, 3.19)P=0.796 2.00 (-0.85, 4.84)P=0.168
Social functioning 2.28 (-0.11, 4.68)P=0.062 2.18 (-0.22, 4.58)P=0.074 0.10 (-2.32, 2.52)P=0.935
Bodily pain 1.90 (-0.36, 4.15)P=0.098 3.20 (0.95, 5.46)P=0.006 -1.31 (-3.58, 0.97)P=0.260
Mental health 2.50 (0.23, 4.77)P=0.031 -0.57 (-2.85, 1.71)P=0.622 3.07 (0.78, 5.37)P=0.009
General health 1.61 (-0.15, 3.37)P=0.073 1.69 (-0.08, 3.45)P=0.061 -0.07 (-1.85, 1.70)P=0.934
PHQ-9 -0.62 (-1.71, 0.48)P=0.268 0.00 (-1.09, 1.09)P=0.998 -0.62 (-1.72, 0.49)P=0.272
